Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine–driven inflammation and fibrosis
Open accessThe DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Thymic stromal lymphopoietin (TSLP), interleukin-25 (IL-25), and IL-33 are important initiators of type 2-associated mucosal inflammation and immunity. However, their role in the maintenance of progressive type 2 inflammation and fibrosis is much less clear. Using chronic models of helminth infection and allergic lung inflammation, we show that collective disruption of TSLP, IL-25, and IL-33 signaling suppresses chronic and progressive type 2 cytokine-driven inflammation and fibrosis. In a schistosome lung granuloma model or during chronic Schistosoma mansoni infection in the liver, individual ablation of TSLP, IL-25, or IL-33/ST2 had no impact on the development of IL-4/IL-13-dependent inflammation or fibrosis. However, significant reductions in granuloma-associated eosinophils, hepatic fibrosis, and IL-13-producing type 2 innate lymphoid cells (ILC2s) were observed when signaling of all three mediators was simultaneously disrupted. Combined blockade through monoclonal antibody (mAb) treatment also reduced IL-5 and IL-13 expression during primary and secondary granuloma formation in the lungs. In a model of chronic house dust mite-induced allergic lung inflammation, combined mAb treatment did not decrease established inflammation or fibrosis. TSLP/IL-33 double-knockout mice treated with anti-IL-25 mAb during priming, however, displayed decreased inflammation, mucus production, and lung remodeling in the chronic phase. Together, these studies reveal partially redundant roles for TSLP, IL-25, and IL-33 in the maintenance of type 2 pathology and suggest that in some settings, early combined targeting of these mediators is necessary to ameliorate progressive type 2-driven disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“integrin receptors that interact with the extracellular matrix were recently shown to preferentially activate TGF-β signaling and production of IL-17A while antagonizing the production of type 2 cytokines142”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [142]
In the citing paper
“several studies have revealed substantial cross-regulation between IL-17A and IL-13110,143, with marked upregulation of the opposing pathway when only one mechanism was targeted therapeutically136,142,144,145”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [142]
Citations
Cites
Functional diversity of helper T lymphocytes
Abbas, A. K., Murphy, K. M., & Sher, A. (1996) · Nature · doi:10.1038/383787a0 · Cited by 4,450 · cited 1×
“In addition to suppressing the proinflammatory activity of type 1 immune responses (2), type 2 immunity regulates wound healing (3), metabolic homeostasis (4), and immunity to several extracellular parasites (5).”
BackgroundSchmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.015 · Cited by 3,710
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
Wynn, T. A., & Ramalingam, T. R. (2012) · Nature Medicine · doi:10.1038/nm.2807 · Cited by 3,541
Self-citationPetry, F. E. (1997) · Kluwer Academic Publishers eBooks · Cited by 2,303
Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP
Soumelis, V., Reche, P. A., Kanzler, H., Yuan, W., Edward, G., Homey, B., Gilliet, M., Ho, S., Antonenko, S., Lauerma, A., et al. (2002) · Nature Immunology · doi:10.1038/ni805 · Cited by 2,183
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
Neill, D. R., Wong, S. H., Bellosi, A., Flynn, R. J., Daly, M., Langford, T. K. A., Bucks, C., Kane, C. M., Fallon, P. G., Pannell, R., et al. (2010) · Nature · doi:10.1038/nature08900 · Cited by 1,938
The immunological and genetic basis of inflammatory bowel disease
Bouma, G., & Strober, W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1132 · Cited by 1,767
Fibrotic disease and the TH1/TH2 paradigm
Wynn, T. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1412 · Cited by 1,765 · cited 2×
“In addition to suppressing the proinflammatory activity of type 1 immune responses (2), type 2 immunity regulates wound healing (3), metabolic homeostasis (4), and immunity to several extracellular parasites (5).”
BackgroundSelf-citationMacrophage-mediated inflammation in metabolic disease
Chawla, A., Nguyen, K. D., & Goh, Y. P. S. (2011) · Nature reviews. Immunology · doi:10.1038/nri3071 · Cited by 1,314 · cited 1×
“In addition to suppressing the proinflammatory activity of type 1 immune responses (2), type 2 immunity regulates wound healing (3), metabolic homeostasis (4), and immunity to several extracellular parasites (5).”
BackgroundIL-25 Induces IL-4, IL-5, and IL-13 and Th2-Associated Pathologies In Vivo
Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T., Hunte, B., Lesley, R., et al. (2001) · Immunity · doi:10.1016/s1074-7613(01)00243-6 · Cited by 1,203
Mjösberg, J. M., Trifari, S., Crellin, N. K., Peters, C. P., van Drunen, C. M., Piet, B., Fokkens, W. J., Cupedo, T., & Spits, H. (2011) · Nature Immunology · doi:10.1038/ni.2104 · Cited by 1,166
Galli, S. J., Borregaard, N., & Wynn, T. A. (2011) · Nature Immunology · doi:10.1038/ni.2109 · Cited by 1,055
Self-citationDisease-associated functions of IL-33: the new kid in the IL-1 family
Liew, F. Y., Pitman, N. I., & McInnes, I. B. (2010) · Nature Reviews Immunology · doi:10.1038/nri2692 · Cited by 1,003
Diversity and dialogue in immunity to helminths
Allen, J. E., & Maizels, R. M. (2011) · Nature reviews. Immunology · doi:10.1038/nri2992 · Cited by 831 · cited 1×
“In addition to suppressing the proinflammatory activity of type 1 immune responses (2), type 2 immunity regulates wound healing (3), metabolic homeostasis (4), and immunity to several extracellular parasites (5).”
Backgroundγ-Secretase-mediated proteolysis in cell-surface-receptor signalling
Fortini, M. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm910 · Cited by 824
Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice
Zhou, B., Comeau, M. R., Smedt, T. D., Liggitt, H. D., Dahl, M. E., Lewis, D. B., Gyarmati, D., Aye, T., Campbell, D. J., & Ziegler, S. F. (2005) · Nature Immunology · doi:10.1038/ni1247 · Cited by 819
Self-citationHalim, T. Y. F., Krauß, R. H., Sun, A. C., & Takei, F. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.020 · Cited by 804
Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses
Gauvreau, G. M., O'Byrne, P. M., Boulet, L.-P., Wang, Y., Cockcroft, D., Bigler, J., FitzGerald, J. M., Boedigheimer, M., Davis, B. E., Dias, C., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402895 · Cited by 789
Self-citationFallon, P. G., Ballantyne, S. J., Mangan, N. E., Barlow, J. L., Dasvarma, A., Hewett, D. R., McIlgorm, A., Jolin, H. E., & McKenzie, A. N. J. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051615 · Cited by 738
TSLP Elicits IL-33–Independent Innate Lymphoid Cell Responses to Promote Skin Inflammation
Kim, B. S., Siracusa, M. C., Saenz, S. A., Noti, M., Monticelli, L. A., Sonnenberg, G. F., Hepworth, M. R., Van Voorhees, A. S., Comeau, M. R., & Artis, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005374 · Cited by 731
Self-citationVan Dyken, S. J., & Locksley, R. M. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095906 · Cited by 714
Innate lymphoid cells — how did we miss them?
Walker, J. A., Barlow, J. L., & McKenzie, A. N. J. (2013) · Nature Reviews Immunology · doi:10.1038/nri3349 · Cited by 669 · cited 5×
“However, the relative importance of IL-25 and IL-33 to the maintenance of established type 2–drivendisease and the potential redundancy of these mediators have not been assessed.”
BackgroundInfluentialIL-33 is a crucial amplifier of innate rather than acquired immunity
Oboki, K., Ohno, T., Kajiwara, N., Arae, K., Morita, H., Ishii, A., Nambu, A., Abe, T., Kiyonari, H., Matsumoto, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003059107 · Cited by 652
TH2, allergy and group 2 innate lymphoid cells
Licona-Limón, P., Kim, L. K., Palm, N. W., & Flavell, R. A. (2013) · Nature Immunology · doi:10.1038/ni.2617 · Cited by 646 · cited 1×
“IL-33 will amplify antigen-dependent and antigenindependent effector responses from both human and mouse TH2 cells (16, 17).”
BackgroundThe Transcription Factor GATA3 Is Essential for the Function of Human Type 2 Innate Lymphoid Cells
Mjösberg, J., Bernink, J., Golebski, K., Karrich, J. J., Peters, C. P., Blom, B., te Velde, A. A., Fokkens, W. J., van Drunen, C. M., & Spits, H. (2012) · Immunity · doi:10.1016/j.immuni.2012.08.015 · Cited by 636
Smithgall, M. D., Comeau, M. R., Park Yoon, B.-R., Kaufman, D., Armitage, R., & Smith, D. E. (2008) · International Immunology · doi:10.1093/intimm/dxn060 · Cited by 619 · cited 1×
“IL-33 will amplify antigen-dependent and antigenindependent effector responses from both human and mouse TH2 cells (16, 17).”
BackgroundSelf-citationThe many paths to asthma: phenotype shaped by innate and adaptive immunity
Kim, H. Y., DeKruyff, R. H., & Umetsu, D. T. (2010) · Nature Immunology · doi:10.1038/ni.1892 · Cited by 588
Interleukin-33-Dependent Innate Lymphoid Cells Mediate Hepatic Fibrosis
Mchedlidze, T., Waldner, M., Zopf, S., Walker, J., Rankin, A. L., Schuchmann, M., Voehringer, D., McKenzie, A. N. J., Neurath, M. F., Pflanz, S., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.07.018 · Cited by 502 · cited 2×
“Although recent studies using hepatotoxic chemicals or schistosome egg– driven models have suggested that IL-33 expression is critical to the development of fibrosis in the liver (32), we observed no reduction in hepatic fibrosis in IL-33 mice at either time point (Fig.”
BackgroundEpithelial-cell-intrinsic IKK-β expression regulates intestinal immune homeostasis
Zaph, C., Troy, A. E., Taylor, B. C., Berman-Booty, L. D., Guild, K. J., Du, Y., Yost, E. A., Gruber, A. D., May, M. J., Greten, F. R., et al. (2007) · Nature · doi:10.1038/nature05590 · Cited by 496
Saenz, S. A., Taylor, B. C., & Artis, D. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00713.x · Cited by 484
Type 2 immunity and wound healing: evolutionary refinement of adaptive immunity by helminths
Gause, W. C., Wynn, T. A., & Allen, J. E. (2013) · Nature Reviews Immunology · doi:10.1038/nri3476 · Cited by 464
Self-citationIL-33, a Potent Inducer of Adaptive Immunity to Intestinal Nematodes
Humphreys, N. E., Xu, D., Hepworth, M. R., Liew, F. Y., & Grencis, R. K. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2443 · Cited by 416
Willart, M. A. M., Deswarte, K., Pouliot, P., Braun, H., Beyaert, R., Lambrecht, B. N., & Hammad, H. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20112691 · Cited by 411
Owyang, A. M., Zaph, C., Wilson, E. H., Guild, K. J., McClanahan, T., Miller, H. R. P., Cua, D. J., Goldschmidt, M., Hunter, C. A., Kastelein, R. A., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051496 · Cited by 379
IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis
Hams, E., Armstrong, M. E., Barlow, J. L., Saunders, S. P., Schwartz, C., Cooke, G., Fahy, R. J., Crotty, T. B., Hirani, N., Flynn, R. J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315854111 · Cited by 376 · cited 2×
“fibrosis by stimulating the production of IL-13 from ILC2s (44, 54).”
BackgroundHydrodynamic Gene Delivery: Its Principles and Applications
Suda, T., & Liu, D. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300314 · Cited by 347
Taylor, B. C., Zaph, C., Troy, A. E., Du, Y., Guild, K. J., Comeau, M. R., & Artis, D. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081499 · Cited by 343 · cited 1×
“Triple block of IL-33, TSLP, and IL-25 with mAbs Anti-mouse ST2 (61), anti-mouse TSLP (38), and anti-mouse IL-25 (62) mAbs were generated and selected by Amgen Inc.”
MethodSelf-citationIncreased expression of immunoreactive thymic stromal lymphopoietin in patients with severe asthma
Shikotra, A., Choy, D. F., Ohri, C. M., Doran, E., Butler, C., Hargadon, B., Shelley, M., Abbas, A. R., Austin, C. D., Jackman, J., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.08.031 · Cited by 333
Rickel, E. A., Siegel, L. A., Yoon, B.-R. P., Rottman, J. B., Kugler, D. G., Swart, D. A., Anders, P. M., Tocker, J. E., Comeau, M. R., & Budelsky, A. L. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4299 · Cited by 321 · cited 1×
“Triple block of IL-33, TSLP, and IL-25 with mAbs Anti-mouse ST2 (61), anti-mouse TSLP (38), and anti-mouse IL-25 (62) mAbs were generated and selected by Amgen Inc.”
MethodSelf-citationWang, Y.-H., Ito, T., Wang, Y.-H., Homey, B., Watanabe, N., Martin, R., Barnes, C. J., McIntyre, B. W., Gilliet, M., Kumar, R., et al. (2006) · Immunity · doi:10.1016/j.immuni.2006.03.019 · Cited by 319
Inhibition of interleukin‐33 signaling attenuates the severity of experimental arthritis
Palmer, G., Talabot‐Ayer, D., Lamacchia, C., Toy, D., Seemayer, C. A., Viatte, S., Finckh, A., Smith, D. E., & Gabay, C. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24305 · Cited by 313 · cited 14×
“We observed similar results using anti-ST2, anti-TSLP, anti–IL-25 neutralizing antibodies in wildtype mice during the entire course of chronic HDM exposure (fig.”
MethodInfluentialSelf-citationChristianson, C. A., Goplen, N. P., Zafar, I., Irvin, C., Good, J. T., Rollins, D. R., Gorentla, B., Liu, W., Gorska, M. M., Chu, H., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.11.037 · Cited by 302
Steinfelder, S., Andersen, J. F., Cannons, J. L., Feng, C. G., Joshi, M., Dwyer, D., Caspar, P., Schwartzberg, P. L., Sher, A., & Jankovic, D. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20082462 · Cited by 294 · cited 1×
“Also, schistosome egg antigens have been identified that are capable of directly activating type 2 responses bymodulatingDC function (46, 47).”
BackgroundCheever, A. W., Williams, M. E., Wynn, T. A., Finkelman, F. D., Seder, R. A., Cox, T. M., Hieny, S., Caspar, P., & Sher, A. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.2.753 · Cited by 275 · cited 1×
“Mice were perfused at the time of euthanasia to determine worm and tissue egg burdens as described previously (59).”
MethodSelf-citationGhia, P., Strola, G., Granziero, L., Geuna, M., Guida, G., Sallusto, F., Ruffing, N., Montagna, L., Piccoli, P., Chilosi, M., et al. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200205)32:5<1403::aid-immu1403>3.0.co;2-y · Cited by 271
Wynn, T. A., Eltoum, I., Oswald, I. P., Cheever, A. W., & Sher, A. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.5.1551 · Cited by 266 · cited 2×
“mansoni infection models because thesemodels provide robust systems to dissect the role of TSLP, IL-25, and IL-33 during both the initiation and maintenance phases of type 2–driven inflammation (31).”
BackgroundSelf-citationVan Dyken, S. J., Mohapatra, A., Nussbaum, J. C., Molofsky, A. B., Thornton, E. E., Ziegler, S. F., McKenzie, A. N. J., Krummel, M. F., Liang, H.-E., & Locksley, R. M. (2014) · Immunity · doi:10.1016/j.immuni.2014.02.003 · Cited by 251
Jankovic, D., Kullberg, M. C., Noben-Trauth, N., Caspar, P., Paul, W. E., & Sher, A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.3047 · Cited by 243
IL-33 Induces IL-13–Dependent Cutaneous Fibrosis
Rankin, A. L., Mumm, J. B., Murphy, E., Turner, S., Yu, N., McClanahan, T. K., Bourne, P. A., Pierce, R. H., Kastelein, R., & Pflanz, S. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903306 · Cited by 216
IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms
Hung, L.-Y., Lewkowich, I. P., Dawson, L. A., Downey, J., Yang, Y., Smith, D. E., & Herbert, D. R. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206587110 · Cited by 206
Self-citationEpithelial Interleukin-25 Is a Key Mediator in Th2-High, Corticosteroid-Responsive Asthma
Cheng, D., Xue, Z., Yi, L., Shi, H., Zhang, K., Huo, X., Bonser, L. R., Zhao, J., Xu, Y., Erle, D. J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201403-0505oc · Cited by 189
Massacand, J. C., Stettler, R. C., Meier, R., Humphreys, N. E., Grencis, R. K., Marsland, B. J., & Harris, N. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906367106 · Cited by 181 · cited 1×
“Sc ment of type 2 responses by directly modulating DC function (28).”
BackgroundIL-25 drives remodelling in allergic airways disease induced by house dust mite
Gregory, L. G., Jones, C. P., Walker, S. A., Sawant, D., Gowers, K. H. C., Campbell, G. A., McKenzie, A. N. J., & Lloyd, C. M. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202003 · Cited by 175
Schramm, G., Mohrs, K., Wodrich, M., Doenhoff, M. J., Pearce, E. J., Haas, H., & Mohrs, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6023 · Cited by 163
Yanaba, K., Yoshizaki, A., Asano, Y., Kadono, T., & Sato, S. (2011) · Clinical Rheumatology · doi:10.1007/s10067-011-1686-5 · Cited by 150
Murakami-Satsutani, N., Ito, T., Nakanishi, T., Inagaki, N., Tanaka, A., Vien, P. T. X., Kibata, K., Inaba, M., & Nomura, S. (2014) · Allergology International · doi:10.2332/allergolint.13-oa-0672 · Cited by 135 · cited 1×
“One recent study revealed that IL-33 can enhance TSLP- and DC-mediated human TH2 memory responses in vitro, suggesting the alarmins could play a role in maintaining immune responses (23).”
BackgroundThe influence of TSLP on the allergic response
Comeau, M. R., & Ziegler, S. F. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.134 · Cited by 123
Self-citationInterleukin-33 Potentiates Bleomycin-Induced Lung Injury
Luzina, I. G., Kopach, P., Lockatell, V., Kang, P. H., Nagarsekar, A., Burke, A. P., Hasday, J. D., Todd, N. W., & Atamas, S. P. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0093oc · Cited by 120 · cited 1×
“Transgenic overexpression of IL-33 has also been shown to promote IL-13–dependent cutaneous fibrosis (55), ILC2-mediated hepatic fibrosis (32), and bleomycin-induced pulmonary fibrosis in mice (56).”
BackgroundCritical Role of IL-25 in Nematode Infection-Induced Alterations in Intestinal Function
Zhao, A., Urban, J. F., Sun, R., Stiltz, J., Morimoto, M., Notari, L., Madden, K. B., Yang, Z., Grinchuk, V., Ramalingam, T. R., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000450 · Cited by 105
Self-citationTSLP and IL-7 use two different mechanisms to regulate human CD4+ T cell homeostasis
Lü, N., Wang, Y., Wang, Y., Arima, K., Hanabuchi, S., & Liu, Y.-J. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090153 · Cited by 97 · cited 4×
“IL-25 and IL-33 exhibit similar TH2-inducing activity, but rather than targeting DCs, myeloid cells, and TH2 cells, they largely promote type 2 immunity by stimulating ILC2s as well as basophils, mast cells, and eosinophils.”
BackgroundInfluentialNoben-Trauth, N., Hu-Li, J., & Paul, W. E. (2002) · European Journal of Immunology · doi:10.1002/1521-4141(200205)32:5<1428::aid-immu1428>3.0.co;2-0 · Cited by 91
Regulation of Helminth-Induced Th2 Responses by Thymic Stromal Lymphopoietin
Ramalingam, T. R., Pesce, J. T., Mentink-Kane, M. M., Madala, S., Cheever, A. W., Comeau, M. R., Ziegler, S. F., & Wynn, T. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900181 · Cited by 57 · cited 3×
“As reported previously with TSLP (26), we observed little to no role for IL-25 or IL-33 in IL-4/IL-13– dependent granuloma formation in the lungs.”
BackgroundInfluentialSelf-citationA profibrotic role for thymic stromal lymphopoietin in systemic sclerosis
Usategui, A., Criado, G., Izquierdo, E., Del Rey, M. J., Carreira, P. E., Ortiz, P., Leonard, W. J., & Pablos, J. L. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202279 · Cited by 52
Jang, S., Morris, S. B., & Lukacs, N. W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056433 · Cited by 45
Profibrotic interleukin-33 is correlated with uterine leiomyoma tumour burden
Santulli, P., Even, M., Chouzenoux, S., Millischer, A., Borghese, B., de Ziegler, D., Batteux, F., & Chapron, C. (2013) · Human Reproduction · doi:10.1093/humrep/det238 · Cited by 36
Research works printed but not linked: 1
- T. A. Wynn L. Barron R. W. Thompson S. K. Madala M. S. Wilson A. W. Cheever T. Ramalingam in Current Protocols in Immunology John E. Coligan et al. Eds. (John Wiley & Sons Inc. New York 2011).
Cited by
Fibrosis: from mechanisms to medicines
Henderson, N. C., Rieder, F., & Wynn, T. A. (2020) · Nature · doi:10.1038/s41586-020-2938-9 · Cited by 1,868
Self-citationLiver Macrophages in Tissue Homeostasis and Disease
Krenkel, O., & Tacke, F. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.11 · Cited by 1,424
Inflammation and metabolism in tissue repair and regeneration
Eming, S. A., Wynn, T. A., & Martin, P. (2017) · Science · doi:10.1126/science.aam7928 · Cited by 1,369
Self-citationInterleukin-33 in health and disease
Liew, F. Y., Girard, J.-P., & Turnquist, H. R. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.95 · Cited by 1,147
Type 2 immunity in tissue repair and fibrosis
Gieseck, R. L., Wilson, M. S., & Wynn, T. A. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.90 · Cited by 1,055
Self-citation
Metadata
- Authors
- Vannella, K. M., Ramalingam, T. R., Borthwick, L. A., Barron, L., Hart, K. M., Thompson, R. W., Kindrachuk, K. N., Cheever, A. W., White, S., Budelsky, A. L., Comeau, M. R., Smith, D. E., & Wynn, T. A.
- Affiliations
- National Institutes of Health (US)
- Amgen (United States) (US)
- Corresponding author
- Wynn, Thomas A.
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2016-05-04
- Volume
- 8
- Issue
- 337
- Pages
- 337ra65-337ra65
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2345448809
- Cited by
- 188
- References
- 64
- Citations by year
- 2026: 15 · 2025: 10 · 2024: 19 · 2023: 13 · 2022: 21 · 2021: 18 · 2020: 19 · 2019: 24 · 2018: 20 · 2017: 25 · 2016: 4
- FWCI
- 14.73
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Intramural Research Program of NIH
- National Institute of Allergy and Infectious Diseases
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
- Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
- Keywords
- thymic stromal lymphopoietin, IL-25, IL-33, ST2, type 2 inflammation, fibrosis, helminthiasis, Schistosoma mansoni, lung granulomas, eosinophils, ILC2, IL-13, IL-4, allergic lung inflammation, house dust mites, mucus production, lung remodeling, monoclonal antibodies
- MeSH terms
- Interleukin-33, Thymic Stromal Lymphopoietin, Animals, Antibodies, Monoclonal, Female, Fibrosis, Granuloma, Inflammation, Lung Neoplasms, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Schistosoma mansoni, Interleukin-4, Cytokines, Mice, Knockout, Interleukin-13, Interleukin-17, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.